Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateCaliforniaHearing Scheduled
AB 2302: Food safety: infant formula.
Celeste Rodriguez
AB 2302 status: Hearing Scheduled — In committee: Set, first hearing. Hearing canceled at the request of author (updated Jul 1, 2026).
Source
LegiScan
Confidence
High
Analysis basis
LegiScan full bill text
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
75OUT OF 100
Score:75/100 civic fit
Risk:Low Risk
Impact:Moderate Impact 65/100
Constitutionality90%
Bipartisan70%
Public opinion85%
Bill summary
Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of various subjects relating to the manufacturing, processing, labeling, advertising, and sale of food, drugs, and cosmetics, under the administration and enforcement of the State Department of Public Health. A violation of these provisions is punishable as a misdemeanor. This bill would require a manufacturer of infant formula for sale or distribution in this state to test its final infant formula product fo...
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
45%
Benefits
- Standards incentivize high-quality production
- Uniform testing improves market legitimacy
- Reduces potential liability from contaminated products
Risks
- Increased testing and laboratory costs
- Administrative burden of managing QR code disclosure
- Risk of market exit by smaller manufacturers
Society
Positive outlook
80%
Benefits
- Improved transparency for parents and caregivers
- Greater access to safety information for infants
- Reduces parental anxiety regarding product quality
Risks
- Complex data may cause confusion for some consumers
- Potential for unnecessary alarm based on trace findings
- Information access relies on digital literacy/tools
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Positive outlook
85%
Benefits
- Establishes mandatory public transparency regarding toxins
- Increases regulatory oversight of formula manufacturers
- Empowers Department of Public Health access to data
Risks
- Adds enforcement complexity for state departments
- Requires ongoing audit of manufacturer compliance
- Relies on self-disclosure subject to audit
Public Health & Safety
Positive outlook
90%
Benefits
- Direct reduction of toxic heavy metal exposure for infants
- Early detection of batch-level contamination
- Promotes alignment with advanced FDA analytical methods
Risks
- Testing interval may miss intermittent contamination
- Thresholds may still allow for low-level exposure
- Focus on heavy metals excludes other potential hazards
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
LegiScan
Official bill text or data from LegiScan.
Confidence
High
Information is complete and verified.
Analysis basis
LegiScan full bill text
Source used for this bill's analysis.
Source note
Compliance costs may disproportionately affect smaller brands.
Analysis scope
Source does not specify enforcement budget impact.
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.